ASTERASYS Co.,Ltd (450950.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea

Price
4,915.00 KRW
Market cap
184.35 bn KRW
P/E (2025)
20.02
P/S (2025)
4.86
Dividend yield
1.06 %
Net margin
24.27 %
Return on equity (ROE)
19.70 %
Return on assets (ROA)
17.64 %

ASTERASYS Co.,Ltd financials

Fiscal year20242025
Revenue28.83 bn KRW37.94 bn KRW
Gross profit20.89 bn KRW30.04 bn KRW
Operating income6.66 bn KRW10.39 bn KRW
EBIT6.84 bn KRW10.85 bn KRW
Net income5.35 bn KRW9.21 bn KRW
Diluted EPS – continuing operations146.57 KRW245.56 KRW

Full history since 2022, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About ASTERASYS Co.,Ltd

ASTERASYS Co.,Ltd manufactures and sells medical equipment for hospitals and skin care devices for beauty care clinics and salons in South Korea, Europe, Asia, the Middle East, Africa, North America, South America, Australia, and New Zealand. The company offers Coolfase, a monopolar RF device with direct cooling in tip; Q-facial, a skin management equipment; Liftera for facial skin lifting; Liftera2, a dual-type HIFU technology that enables combination treatments using Line and Pen-type applicators; and Futera Dots for fractional skin resurfacing. It serves healthcare, aesthetics, distribution, and IoT sectors. The company was formerly known as DAIHAN Biomedical Co., Ltd. and changed its name to ASTERASYS Co.,Ltd in January 2018. The company was founded in 2015 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.